RINL Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-85640
Key Product Details
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the N-terminal region of Human RINL. Peptide sequence: ETHRGWGREQTPQETEPEAAQRHDPAPRNPAPHGVSWVKGPLSPEVDHPG The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for RINL Antibody
Western Blot: RINL Antibody [NBP2-85640]
Western Blot: RINL Antibody [NBP2-85640] - WB Suggested Anti-RINL Antibody. Titration: 1.0 ug/ml. Positive Control: HepG2 Whole CellImmunoprecipitation: RINL Antibody [NBP2-85640]
Immunoprecipitation: RINL Antibody [NBP2-85640] - Amount and Sample Type: GFP-hRinl transfected COS7 cell lysate. Amount of IP Antibody: 10ug. Primary Antibody: anti-GFP. Primary Antibody Dilution: 1:1000. Secondary Antibody: Goat anti-rabbit-HRP. Secondary Antibody Dilution: 1:5000. Gene Name: RINL. Submitted by: Barbara Woller; Medical University of ViennaApplications for RINL Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: RINL
Alternate Names
FLJ44131, FLJ45909, Ras and Rab interactor-like, ras and Rab interactor-like protein
Gene Symbol
RINL
Additional RINL Products
Product Specific Notices for RINL Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...